Leo Wealth LLC Sells 188 Shares of The Clorox Company (NYSE:CLX)

Leo Wealth LLC reduced its position in The Clorox Company (NYSE:CLX) by 6.6% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,643 shares of the company’s stock after selling 188 shares during the quarter. Leo Wealth LLC’s holdings in Clorox were worth $431,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also modified their holdings of the company. GoalVest Advisory LLC bought a new position in Clorox in the 1st quarter worth $31,000. First Foundation Advisors bought a new position in shares of Clorox in the first quarter worth about $31,000. Innealta Capital LLC purchased a new stake in shares of Clorox during the second quarter worth about $30,000. Trifecta Capital Advisors LLC raised its stake in Clorox by 139.8% during the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock valued at $30,000 after purchasing an additional 130 shares during the period. Finally, Quarry LP lifted its holdings in Clorox by 99.1% in the 2nd quarter. Quarry LP now owns 229 shares of the company’s stock worth $31,000 after purchasing an additional 114 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors.

Clorox Stock Down 0.7 %

Shares of NYSE CLX opened at $159.23 on Wednesday. The company has a market cap of $19.77 billion, a P/E ratio of 82.50, a PEG ratio of 3.19 and a beta of 0.41. The firm has a 50-day simple moving average of $159.96 and a two-hundred day simple moving average of $145.33. The Clorox Company has a 1 year low of $114.68 and a 1 year high of $169.09. The company has a debt-to-equity ratio of 5.04, a current ratio of 1.03 and a quick ratio of 0.63.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Thursday, August 1st. The company reported $1.82 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.54 by $0.28. The company had revenue of $1.90 billion during the quarter, compared to analysts’ expectations of $1.97 billion. Clorox had a return on equity of 281.12% and a net margin of 3.95%. Research analysts anticipate that The Clorox Company will post 6.64 earnings per share for the current year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd will be issued a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.06%. The ex-dividend date of this dividend is Wednesday, October 23rd. Clorox’s payout ratio is presently 252.85%.

Wall Street Analyst Weigh In

CLX has been the subject of a number of research analyst reports. JPMorgan Chase & Co. increased their price objective on shares of Clorox from $148.00 to $174.00 and gave the company a “neutral” rating in a report on Friday, October 11th. TD Cowen assumed coverage on Clorox in a report on Tuesday, July 23rd. They issued a “sell” rating and a $122.00 target price on the stock. Evercore ISI cut their price target on Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a report on Monday, October 14th. BNP Paribas raised Clorox to a “strong sell” rating in a report on Friday, September 6th. Finally, Citigroup raised their target price on shares of Clorox from $165.00 to $170.00 and gave the company a “neutral” rating in a report on Friday, September 6th. Six research analysts have rated the stock with a sell rating, nine have assigned a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat, Clorox presently has a consensus rating of “Hold” and an average target price of $150.14.

Insider Buying and Selling

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the company’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the transaction, the executive vice president now directly owns 13,471 shares in the company, valued at $2,229,719.92. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.51% of the stock is currently owned by insiders.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.